(Q51595095)
Statements
1 reference
Efficacy of 24-week monotherapy with acarbose, glibenclamide, or placebo in NIDDM patients. The Essen Study. (English)
1 reference
Hoffmann J
1 reference
Spengler M
1 reference
1 June 1994
1 reference
1 reference
17
1 reference
561-566
1 reference
6
1 reference
Identifiers
1 reference